Procter & Gamble Hygiene and Health Care · NSE: PGHH · BSE: 500459
Q1 FY23 results · Apr–Jun 2022
Procter & Gamble Hygiene and Health Care reported revenue from operations of ₹776.38 crore (down 1.3% from Q1 FY22) and net profit of ₹42.55 crore (down 13.1% from Q1 FY22) for Q1 FY23 (Apr–Jun 2022), on a standalone basis.
| Item | Q1 FY23 | Q1 FY22 | YoY | Q4 FY22 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 776.38 | 786.59 | −1.3% | 973.26 | −20.2% |
| Other income | 5.63 | 5.72 | −1.6% | 6.03 | −6.6% |
| Total income | 782.01 | 792.31 | −1.3% | 979.29 | −20.1% |
| Profit before tax | 57.70 | 67.25 | −14.2% | 151.10 | −61.8% |
| Net profit for the period | 42.55 | 48.98 | −13.1% | 102.85 | −58.6% |
| EPS, basic (₹) | 13.11 | 15.09 | −13.1% | 31.68 | −58.6% |
| Net margin (%) | 5.5 | 6.2 | 10.6 |
Standalone
- Filed with BSE
- 24 Aug 2022, 11:23 IST
- Board meeting
- 23 Aug 2022
- Period
- 01 Apr 2022 to 30 Jun 2022
- Review status
- Audited
- Source
- XBRL filing on BSE